Core Committee

 

Annamaria de Luca Annamaria de Luca - Committee Chair

Professor of Pharmacology - University of Bari

Annamaria is a pharmacologist specialized in pre-clinical in vivo and ex vivo studies of inherited and acquired neuromuscular disorders. In this general frame, she has a long lasting experience in preclinical research on pharmacological treatments for DMD and collaborates with leading scientists in the field.


Call +38 0805 442245

 

Didier Caizergues Didier Caizergues - Regulatory Expert

Head of Regulatory Affairs and Quality Assurance - Généthon

Didier is a pharmacist specialised in Regulatory Affairs and also in product development.  Since 2001 he has worked for GENETHON where he has successfully obtained Orphan Drugs designations and Clinical Trial Authorisations for gene therapy products in the field of NMD in several European countries.

More Info

 

James Dowling James Dowling

Mogford Campbell family chair in paediatric neurosciences, Associate Professor of Paediatrics and Molecular Genetics - University of Toronto - Généthon

Dr. Jim Dowling is a clinician-scientist focused on gene discovery and therapy development for childhood muscle diseases.  He is a staff clinician and senior scientist at the Hospital for Sick Children as well as the Mogford Campbell family chair in paediatric neurosciences, and an Associate Professor of Paediatrics and Molecular Genetics at the University of Toronto.

More Info

 

Nathalie Goemans Nathalie Goemans

M.D - UZ Leuven

Dr Nathalie Goemans (M.D. PhD) is a paediatrician and child neurologist, with certification in rehabilitation medicine and is currently head of the Neuromuscular Reference Centre within the department of Paediatrics and Child Neurology at  the University Hospitals Leuven, Belgium, and consultant in neuropediatrics at DVC St Jozef Antwerp, Belgium, a rehabilitation centre with residential setting for neuromuscular patients.


Call +32 16 34 38 45

 

Heather Gordish-Dressman Heather Gordish-Dressman

Assistant Professor of Pediatrics - UZ Leuven

Dr. Gordish-Dressman is an Assistant Professor of Pediatrics at George Washington University School of Medicine and Health Sciences and the Center for Translational at Children's National Health System and is a statistician focusing on in neuromuscular diseases.

 

Miranda Grounds Miranda Grounds

Professor - University of Western Australia

Miranda has devoted over 30 years of research to better understanding the process of damage and repair of normal skeletal muscle.

 

Michael  Kelly Michael Kelly

Chief Scientific Officer - CureDuchenne

Dr. Michael Kelly is Chief Scientific Officer of CureDuchenne. Dr. Kelly, a senior pharmaceutical executive, brings more than 25 years of experience in drug discovery and development to the organization. He is responsible for advancing drug development programs and identifying new drug targets that exhibit potential to transform the treatment of Duchenne muscular dystrophy.

More Info

 

Anna Mayhew Anna Mayhew

Consultant Research Physiotherapist - Newcastle University

Dr Anna Mayhew is a Consultant Research Physiotherapist at The MRC Centre for Neuromuscular Diseases at Newcastle, Newcastle University.

 

Elizabeth McNally Elizabeth McNally - Clinical Representative

Ward Professor and Director - Northwestern University Feinberg School of Medicine

Elizabeth McNally is Ward Professor and Director at Center for Genetic Medicine, Northwestern University Feinberg School of Medicine.  Professor McNally has led preclinical and clinical research on inherited cardiovascular and neuromuscular diseases. Her expertise in the genetic mechanisms of cardiomyopathies and muscular dystrophies has led to new insight about how heart failure and muscle dysfunction occur.

More Info

 

Kathryn Wagner Kathryn Wagner - Clinical expert/former chair

Professor of Neurology - The Johns Hopkins School of Medicine

Kathryn R. Wagner, M.D., Ph.D. is the Director of the Center for Genetic Muscle Disorders at the Kennedy Krieger Institute and Associate Professor of Neurology and Neuroscience at the Johns Hopkins School of Medicine. She treats patients with muscular dystrophies in a multidisciplinary clinic, addressing the multiple medical and social issues affecting these individuals and families.

More Info

Call +1 443 923 9525

 

Tracey Zoetis Tracey Zoetis

Consultant for - SciLucent, LLC.

Tracey Zoetis, M.S. advises sponsors on regulatory and pharmacology/toxicology issues for FDA-regulated products, including pharmaceuticals, biologics, medical devices, and combination products. Her more than 25 years of experience in toxicology has afforded her a broad perspective on varied and interesting product safety issues. She has been employed by two major CROs, the FDA, and both large and small consulting firms.